On 5th February 2020, HELIX IMMUNO-ONCOLOGY S.A. submitted the following documents related to the financial year lasting from 1st August 2018 to 31st July 2019 at the Repository of Financial Documents:

  1. Financial statement,
  2. Report on business activities,
  3. Auditor’s opinion / report on the audit of the annual financial statement
  4. Resolution on allocation of profit or loss coverage,
  5. Resolution on approval of the annual financial statement.